Dr. Mehra Discusses DNA Repair Enzymes

Video

In Partnership With:

Dr. Ranee Mehra from Fox Chase Cancer Center Discusses DNA Repair Enzymes

Ranee Mehra, MD, Medical Oncology, head and neck care team, lung cancer care team, Fox Chase Cancer Center, discusses the use of DNA repair enzymes, such as ERCC1, as predictive markers for resistance and survival in head and neck cancer patients.

Mehra explains that in a retrospective tumor sample analysis of patient that had received induction regimens follow by radiation or concurrent chemo radiation there was a clear trend towards improved response and survival outcomes for the patients with a lower expression of DNA repair enzymes.

This retrospective analysis will help establish further hypotheses. The role of DNA repair enzymes needs further investigation but does suggest a possible connection between low levels of the marker and resistance to platinum based or radiation therapy.

Related Videos
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD